NASDAQ: CSCI
Cosciens Biopharma Inc Stock Ownership - Who owns Cosciens Biopharma?

Insider buying vs selling

Have Cosciens Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CSCI insiders and whales buy or sell their stock.

CSCI Shareholders

What type of owners hold Cosciens Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
National Bank Of Canada0.19%5,920$18.56kInstitution
Royal Bank Of Canada0.13%3,936$12.34kInstitution
Federation Des Caisses Desjardins Du Quebec0.12%3,873$12.14kInstitution
Td Waterhouse Canada Inc0.12%3,717$11.65kInstitution
Mai Capital Management0.04%1,151$3.61kInstitution
Citigroup Inc0.03%902$2.83kInstitution
Ubs Group Ag0.02%686$2.15kInstitution
Morgan Stanley0.01%400$1.25kInstitution
Sbi Securities Co Ltd0.01%165$517.28Institution
Bnp Paribas Financial Markets0.00%100$313.50Institution

1 of 2

CSCI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSCI0.67%0.00%
ICU1.27%98.73%Net Buying
BTAI4.15%95.85%Net Selling
ERNA0.85%99.15%Net BuyingNet Buying
HOTH1.85%57.63%Net Buying

Cosciens Biopharma Stock Ownership FAQ

Who owns Cosciens Biopharma?

Cosciens Biopharma (NASDAQ: CSCI) is owned by 0.67% institutional shareholders, 0.00% Cosciens Biopharma insiders, and 99.33% retail investors. National Bank Of Canada is the largest individual Cosciens Biopharma shareholder, owning 5920.00 shares representing 0.19% of the company. National Bank Of Canada's Cosciens Biopharma shares are currently valued at $20.78k.

If you're new to stock investing, here's how to buy Cosciens Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.